decreased circulating VLDL cholesterol level_Apoe<tm2(APOE*3)Mae>/Apoe<tm2(APOE*3)Mae>

http://metadb.riken.jp/0005146I129P2OlaHsdC57BL6JApoetm2APOE3MaeApoetm2APOE3MaeApoetm2APOE3Mae

decreased circulating VLDL cholesterol level_Apoe<tm2(APOE*3)Mae>/Apoe<tm2(APOE*3)Mae>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• apolipoprotein E
  http://metadb.riken.jp/db/mgi_rdf/MGI:88057

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Apoe<tm2(APOE*3)Mae>/Apoe<tm2(APOE*3)Mae>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Apoe<tm2(APOE*3)Mae>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased circulating VLDL cholesterol level
  http://purl.obolibrary.org/obo/MP_0005146

文献

http://purl.org/net/cito/citesAsAuthority

• C. Knouff, et.al., Apo E structure determines VLDL clearance and atherosclerosis risk in mice., The Journal of clinical investigation, 1999, 103
  http://rdf.ncbi.nlm.nih.gov/pubmed/10359567